Harvard Catalyst and InnoCentive Innovation Prize

"Open Innovation Finds The Cure for Type 1 Diabetes - Thanks to Harvard Catalyst, InnoCentive & You!"

How's that for a breaking headline? Could it actually be possible? That's what the minds over at Harvard Catalyst | The Harvard Clinical and Translational Science Center are wondering - can the open innovation approach be used to address challenging health related questions?

Using federal stimulus funding from the National Institutes of Health, Harvard Catalyst has teamed up with InnoCentive, to explore whether open innovation and crowd-sourcing, can spark new directions, collaborations and research in the healthcare community.

Type 1 Diabetes
What Do We Not Know
to Cure Type 1 Diabetes?
Reward: $5,000 USD

This Challenge is asking InnoCentive Solvers to formulate well-defined problems aimed at advancing our knowledge about Type 1 Diabetes and ultimately eradication of the disease. This is an Ideation Challenge with a guaranteed award for at least one submitted solution.

Interested In Participating In This Challenge? See Below... Start Here if you are a member of the Harvard Community Read Details

Start Here if you are not from the Harvard Community Read Details
Harvard Catalyst and InnoCentive invite and encourage the entire Harvard community - faculty, students, and administrators and staff of all levels and specialties, including those at the university's affiliated academic healthcare centers – to register on the InnoCentive website and pose a question or propose an idea, even if they have never been directly involved in the study of Type 1 diabetes or the care of patients with Type 1 diabetes.